I recommend you to take a look at this interesting article from the outgoing chief of Eli Lilly.
Eli Lilly's Sidney Taurel: 'Tailored Therapeutics' -- the Pharmaceutical Industry's Next Blockbuster?
It discuss the changing focus on the Pharma Industry. These changes will impact all you outsourcing experts.
The new paradigm is going to be smaller, quicker, cheaper.
Posts
AI Hasn’t Changed the Value Curve of Spend Analysis — It’s Accelerated the
Need for Tools to Address It
-
In our last post on how AI increases the need for manual spend analysis, we
noted that the claims that AI negates the need for manual spend analysis is
all...
No comments:
Post a Comment